141 related articles for article (PubMed ID: 25609323)
1. Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report.
Vitale J; Convers KD; Goretzke S; Guzman M; Noyes B; Parkar N; Knutsen AP
J Allergy Clin Immunol Pract; 2015; 3(2):273-6. PubMed ID: 25609323
[No Abstract] [Full Text] [Related]
2. Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.
Moctezuma SI; Panizo CM; Landecho MF
Med Clin (Barc); 2017 Oct; 149(7):312-313. PubMed ID: 28736065
[No Abstract] [Full Text] [Related]
3. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
[TBL] [Abstract][Full Text] [Related]
4. Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency.
Tessarin G; Bondioni MP; Rossi S; Palumbo L; Soresina A; Badolato R; Plebani A; Lougaris V
J Investig Allergol Clin Immunol; 2019 Dec; 29(6):470-471. PubMed ID: 31825316
[No Abstract] [Full Text] [Related]
5. Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.
Pathria M; Urbine D; Zumberg MS; Guarderas J
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335365
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency.
Cereser L; De Carli R; Girometti R; De Pellegrin A; Reccardini F; Frossi B; De Carli M
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1055-1057.e2. PubMed ID: 30408616
[No Abstract] [Full Text] [Related]
7. Granulomatous-Lymphocytic Interstitial Lung Disease in a Patient With Common Variable Immunodeficiency.
Shah JL; Amin SB; Verma N; Mohammed TL
Curr Probl Diagn Radiol; 2018; 47(4):282-284. PubMed ID: 28583689
[TBL] [Abstract][Full Text] [Related]
8. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
[TBL] [Abstract][Full Text] [Related]
9. Successful rituximab treatment of granulomatous/lymphocytic interstitial lung disease in common variable immunodeficiency.
Králíčková P; Kubcová Š; Kočová E; Bartoš V; Souček O; Rozsíval P; Vaníček H; Krčmová I; Ravčuková B; Grombiříková H; Freiberger T
Epidemiol Mikrobiol Imunol; 2018; 67(3):142-148. PubMed ID: 30602282
[TBL] [Abstract][Full Text] [Related]
10. Rituximab as a single agent for successful treatment of granulomatous and lymphocytic interstitial lung disease in a pediatric patient with common variable immunodeficiency.
Kosinski SM; Nachajon RV; Milman E
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):876-878.e1. PubMed ID: 34718215
[No Abstract] [Full Text] [Related]
11. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
[TBL] [Abstract][Full Text] [Related]
12. Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings.
Torigian DA; LaRosa DF; Levinson AI; Litzky LA; Miller WT
J Thorac Imaging; 2008 Aug; 23(3):162-9. PubMed ID: 18728542
[TBL] [Abstract][Full Text] [Related]
13. [Combined variable immunodeficiency with unusal features. A case report].
De Charry F; Peterschmitt Tonetti A; De Charry C; Baseggio L; Pasquet F; Khenifer S; Rassat R; Pavic M
Rev Med Interne; 2015 May; 36(5):359-62. PubMed ID: 24630587
[TBL] [Abstract][Full Text] [Related]
14. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
Chase NM; Verbsky JW; Hintermeyer MK; Waukau JK; Tomita-Mitchell A; Casper JT; Singh S; Shahir KS; Tisol WB; Nugent ML; Rao RN; Mackinnon AC; Goodman LR; Simpson PM; Routes JM
J Clin Immunol; 2013 Jan; 33(1):30-9. PubMed ID: 22930256
[TBL] [Abstract][Full Text] [Related]
15. Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases.
Rao N; Mackinnon AC; Routes JM
Hum Pathol; 2015 Sep; 46(9):1306-14. PubMed ID: 26138782
[TBL] [Abstract][Full Text] [Related]
16. Diffuse granulomatous disease: looking inside and outside the lungs.
Williams A; Kelleher WP; Nicholson AG; Devaraj A; Pavesio C; Chua F
Thorax; 2020 Feb; 75(2):189-191. PubMed ID: 31907202
[No Abstract] [Full Text] [Related]
17. British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.
Hurst JR; Verma N; Lowe D; Baxendale HE; Jolles S; Kelleher P; Longhurst HJ; Patel SY; Renzoni EA; Sander CR; Avery GR; Babar JL; Buckland MS; Burns S; Egner W; Gompels MM; Gordins P; Haddock JA; Hart SP; Hayman GR; Herriot R; Hoyles RK; Huissoon AP; Jacob J; Nicholson AG; Rassl DM; Sargur RB; Savic S; Seneviratne SL; Sheaff M; Vaitla PM; Walters GI; Whitehouse JL; Wright PA; Condliffe AM
J Allergy Clin Immunol Pract; 2017; 5(4):938-945. PubMed ID: 28351785
[TBL] [Abstract][Full Text] [Related]
18. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins.
Arish N; Eldor R; Fellig Y; Bogot N; Laxer U; Izhar U; Rokach A
Thorax; 2006 Dec; 61(12):1096-7. PubMed ID: 17114373
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency.
Nishimura M; Miyata J; Tanigaki T; Nomura S; Serizawa Y; Igarashi S; Itou K; Ohno T; Kurata Y; Kimizuka Y; Fujikura Y; Sekinaka Y; Sekinaka K; Matsukuma S; Nonoyama S; Kawana A
Intern Med; 2023 Mar; 62(6):871-875. PubMed ID: 35945007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]